TWA
GILD icon

Tillar-Wenstrup Advisors’s Gilead Sciences GILD Stock Holding History

Tillar-Wenstrup Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,058
Closed -$1.83M – 47
2015
Q4 		$1.83M Sell
18,058
-177
-1% -$18.4K 1.81% 30
2015
Q3 		$1.79M Sell
18,235
-107
-0.6% -$11.9K 1.8% 35
2015
Q2 		$2.15M Buy
+18,342
New +$2M 1.94% 27

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tillar-Wenstrup Advisors's GILD Position: Q1 2016 in Review

Tillar-Wenstrup Advisors sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 18,058 shares — an estimated $1.83M sold.

Tillar-Wenstrup Advisors first reported a position in GILD in Q2 2015 and held it in 3 quarters. The position peaked at $2.15M in Q2 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Tillar-Wenstrup Advisors reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Tillar-Wenstrup Advisors sold 18,058 Gilead Sciences shares in Q1 2016, an estimated $1.83M.
  • Tillar-Wenstrup Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 3 quarters.
  • Tillar-Wenstrup Advisors's Gilead Sciences position peaked at $2.15M in Q2 2015.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Tillar-Wenstrup Advisors's 13F filing for Q1 2016, filed 4 May 2016.